Nearly a year ago, Miller School of Medicine cardiologist Robert J. Myerburg, M.D., was contacted by Michael R. Rosen, M.D., a colleague at Columbia University Medical Center’s Department of Pharmacology. Rosen, a productive basic scientist with a background in cardiology, wanted to talk to his long-time friend about stem cell research.
The University of Miami Miller School of Medicine is the No. 2 medical school in the country for Hispanic students, according to Hispanic Business Magazine’s 2014 Annual Diversity Report.
For The Miami Project to Cure Paralysis, a Center of Excellence at the Miller School of Medicine, 2014 has been a banner year. Its researchers have been using a bench-to-bedside-and-back-again approach to more efficiently share the findings of their advanced discovery science, translational studies, clinical investigations and FDA-approved trials.
In a deal that may lead to the first viable treatment for retinal diseases, Amarantus Bioscience Holdings, Inc., a biotechnology company, has exercised its exclusive right to license intellectual property related to a protein product developed by a researcher at the Miller School of Medicine’s Bascom Palmer Eye Institute.
Sonjia Kenya, Ed.D., M.S., M.A., assistant research professor of medicine, has been named by Legacy magazine as one of Miami-Dade County's 25 Most Influential and Prominent Black Women in Business and Leadership for 2014.